Comparative Pharmacology
Head-to-head clinical analysis: DIALYTE LM DEXTROSE 2 5 IN PLASTIC CONTAINER versus DIALYTE W DEXTROSE 1 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIALYTE LM DEXTROSE 2 5 IN PLASTIC CONTAINER versus DIALYTE W DEXTROSE 1 5 IN PLASTIC CONTAINER.
DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER vs DIALYTE W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dialysis solution containing dextrose and electrolytes; dextrose provides osmotic gradient for ultrafiltration and caloric supplementation, while electrolytes maintain acid-base and electrolyte balance in peritoneal dialysis.
Removes uremic toxins, corrects electrolyte imbalances, and removes excess fluid via peritoneal dialysis.
Intravenous infusion, 500-2000 mL per day as maintenance fluid; rate adjusted based on clinical status, typically 1-2 mL/kg/hour in adults.
Intraperitoneal administration: 2 liters per exchange, 4 exchanges per day (typical for continuous ambulatory peritoneal dialysis).
None Documented
None Documented
Terminal half-life: 2.5–3.5 hours. Clinically, this allows for rapid clearance; accumulation may occur in renal impairment.
Dextrose: ~2-2.5 hours (glucose turnover); electrolytes and lactate have rapid distribution and elimination half-lives of minutes to hours. In renal impairment, half-life of dialyzed solutes may be prolonged.
Renal: >95% as unchanged drug and metabolites. Biliary/fecal: <5%.
Primarily renal; glucose and electrolytes are reabsorbed or excreted by kidneys. For IP administration, dialysis fluid components (e.g., dextrose, sodium, chloride, lactate) are absorbed and then eliminated via renal and metabolic pathways: ~60% of absorbed dextrose is metabolized, remainder excreted renally; electrolytes are excreted renally; lactate is metabolized to bicarbonate.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution